Advertisement

Donald Coffey, PhD, Prostate Cancer Expert, Dies at 85

Advertisement

Donald Coffey, PhD, a distinguished Johns Hopkins professor and prostate cancer expert, who was the former Director of the Brady Urological Research Laboratory and Deputy Director of the Johns Hopkins Kimmel Cancer Center, died on November 9 at the age of 85.

Long Career at Johns Hopkins

In his more than 50 years at Johns Hopkins, Dr. Coffey amassed a long list of accomplishments. He chaired the Department of Pharmacology without ever taking a course in pharmacology. With no medical degree, he helped found the Cancer Center in 1973 with its first Director, Albert Owens, MD, and then ran it briefly in 1987.

Dr. Coffey, who became one of Johns Hopkins’ first triple professors, began his career washing glassware for graduate students. He worked at Westinghouse designing radar antennas during the day, and in the evening, he took classes and worked in the urology laboratory. In 1959, he was named the Director of the Brady Urological Research Laboratory. After a year of running the lab, he was accepted into the Johns Hopkins University School of Medicine’s graduate program in biochemistry.

In 1964, Coffey earned his PhD at 33 years of age, and by then, he had already been a chemist, an engineer, a laboratory director, and prostate cancer researcher. He became the Catherine Iola and J. Smith Michael Distinguished Professor of Urology—as well as professor of oncology; pharmacology and molecular sciences; and pathology—and a member of the professional staff of the Applied Physics Laboratory.

Dr. Coffey’s early research was in many ways the bedrock on which modern genetic and epigenetic discoveries at Johns Hopkins were built. In 1974, he challenged the popular thought on how DNA was copied, looking instead to the core of the nucleus. At the time, it was a revolutionary idea. Most scientists believed there was nothing inside the core. Dr. Coffey brought together two young scientists who were new to the field of cancer research and are now leaders in cancer immunology and cancer genetics: Drew Pardoll, MD, PhD, and Bert Vogelstein, MD.

Dr. Coffey revealed that the nucleus has a skeleton, which he dubbed the nuclear matrix.

He described cancer as the body’s genetic tape playing the wrong song at the wrong time and set out to discover what decides which tape is played and when, and how that contributes to the uncontrolled cell growth that is the hallmark of cancer.

“He may be the most remarkable person I’ve ever met. His impact on cancer and the people who will ultimately solve the cancer problem is immeasurable,” said William Nelson, MD, PhD, Director of the Cancer Center and a former trainee of Dr. Coffey’s.

Beloved Teacher

Coffey was a beloved teacher and mentor and was well-known for using Slinkies, soap bubbles, soda cans, and more to illustrate a point. For his nuclear matrix work, he bought a jigsaw and built an award-winning scale model—175 feet long—of a relaxed single loop of DNA magnified 25,000 times. For Dr. Coffey, neither the classroom nor the laboratory ever closed. In the hallways of Johns Hopkins, in his office over high tea, or in a conference room, he could be found fostering collaborations and inspiring innovative ideas about cancer.

“As the patriarch of prostate cancer research, his teaching influenced entire generations of cancer researchers worldwide. He was the original pioneer of bench-to-bedside research, now known as translational medicine. He was innovative, always thinking, and full of creativity,” said William Isaacs, PhD, Professor of Urology, who came to Johns Hopkins in 1977 as a laboratory technician for Dr. Coffey. “He changed people’s lives in a single hour. It’s impossible to exaggerate the impact he had. He loved science, but he really loved helping people. He had a gift for connecting with people.”

Dr. Coffey also suffered from dyslexia, a disorder that caused him to struggle as a student but helped make him one of Johns Hopkins’ greatest teachers. He was recently awarded the Dean’s Distinguished Mentoring Award.

“Don touched so many of us in such profound ways that it is hard to imagine life without him. We know how fortunate we have been to know him and experience his special and wonderful uniqueness. So, we are only really without him in body, but not in soul,” said Kenneth Pienta, MD, Director of Research for the Brady Urological Institute at Johns Hopkins and the Donald S. Coffey Professor of Urology.

Role at AACR

Dr. Coffey was also a former President of the American Association for Cancer Research (AACR). His many awards included the Fuller Award and Lifetime Achievement Award from the American Urological Association, an American Cancer Society Distinguished Service Award, and the AACR Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research.

“The AACR is deeply saddened by the loss of Dr. Coffey, a Past President of the AACR and Fellow of the AACR Academy,” said Margaret Foti, PhD, MD (hc), Chief Executive Officer of the AACR. “His outstanding leadership skills, dedication to mentoring young investigators, passionate advocacy for sustained increases in funding for cancer research, and remarkable ability to translate complex scientific concepts into lay language made him an icon in the field and a true champion of cancer research. In his memory and honor, we will do our utmost to work even harder to expedite the prevention and cure of all cancers.”

Born in Bristol, Tennessee, on October 10, 1932, Coffey is survived by his wife, Eula; his daughters, Kathryn Whitehead and Carol Burns; and many grandchildren and great-grandchildren.

The content in this post has not been reviewed by the American Society of Clinical Oncology, Inc. (ASCO®) and does not necessarily reflect the ideas and opinions of ASCO®.


Advertisement

Advertisement




Advertisement